ArticleMikrochimica acta2026
A dual‑site reactive ratiometric fluorescent probe for spermine and spermidine discrimination with visualizable sensing.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bioamines spermine and spermidine, which are structurally similar and often coexist in complex matrices, still pose substantial challenges for achieving efficient detection of one another. To address this, a novel coumarin-based fluorescent probe, DX-Cl-CN has been developed. By introducing a chlorine atom and a vinylene-linked dicyanopropene motif as two dual reactive sites, the probe enables specific, differential responses toward spermine and spermidine across various bioamines. In DMSO, its maximum emission wavelength reaches 598 nm. Increasing solvent polarity induces a red shift in emission due to excited-state stabilization and enhanced molecular planarity. When interacting with spermine or spermidine, the probe exhibits a distinctive two-stage blue shift in fluorescence emission: its emission peak first shifts from 598 to 550 nm, then further to 486 nm. Ratiometric fluorescence analysis based on I
Indexed as
Identifiers
42687056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.